These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19351731)

  • 1. Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp.
    Veldhuis JD; Bowers CY
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2544-50. PubMed ID: 19351731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
    Veldhuis JD; Bowers CY
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
    Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C; Miles J; Bowers CY; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R712-9. PubMed ID: 23485864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD; Norman C; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4753-60. PubMed ID: 22990092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.
    Soares-Welch C; Farhy L; Mielke KL; Mahmud FH; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2225-32. PubMed ID: 15634714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
    Paulo RC; Cosma M; Soares-Welch C; Bailey JN; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Mar; 93(3):944-50. PubMed ID: 18073313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
    Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite control of growth hormone secretion in women during controlled estradiol repletion.
    Veldhuis JD; Cosma M; Erickson D; Paulo R; Mielke K; Farhy LS; Bowers CY
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2336-45. PubMed ID: 17405836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Gouwy S; Stockman W; Weekers F; Schetz M; Lauwers P; Bouillon R; Bowers CY
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):599-612. PubMed ID: 9425400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.
    Veldhuis JD; Hudson SB; Erickson D; Bailey JN; Reynolds GA; Bowers CY
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E367-74. PubMed ID: 19470834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.
    Iranmanesh A; Bowers CY; Veldhuis JD
    Eur J Endocrinol; 2010 Jun; 162(6):1043-9. PubMed ID: 20299490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.
    Veldhuis JD; Mielke KL; Cosma M; Soares-Welch C; Paulo R; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2009 Mar; 94(3):973-81. PubMed ID: 19088159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.